Inside Innovation

The Allen Institute, a nonprofit biotech research institution, is expanding into a new life sciences and technology campus near its South Lake Union headquarters. The

Shape Therapeutics, a Seattle-based biotech company, has been included in Fierce Biotech’s 2022 Fierce 15. This year’s list features a diverse range of companies with

Seattle-based biotech Good Therapeutics is being acquired by Swiss Pharmaceutical giant Roche for $250 million, plus further payments for specified milestones. Once the acquisition is

Seattle-based research institution Fred Hutch has received a $78 million gift from Stuart and Molly Sloan to launch a new institute dedicated to oncology research.

Seattle is on the rise as one of biopharma’s hottest spaces in cell and gene therapy. The BioForest region of Washington and Oregon continues to

Seattle-based biotech startup, Immusoft received the green light to start clinical trials to treat MPS I, a rare, lethal childhood disease. This approval makes it

Vilya Inc., the newest spinout from the University of Washington’s Institute of Protein Design (IPD), raised $50 million in a series A funding round. Vilya

Ora Biomedical is planting roots in the Puget Sound region with plans to open a drug-discovery laboratory. The company recently announced a $500,000 pre-seed round

Seattle-based mental health startup Alongside has received $5.5 million in seed funding, with plans to partner with schools to support adolescent mental health and continue

Preclinical biotech company Sonoma Biotherapeutics has announced plans to build an 83,000-square-foot manufacturing and research center on Seattle’s waterfront. The new facility will be used

Pattern Computer, a Seattle-based startup, is developing a rapid COVID-19 test based on patterns in light from spit. In its seven years as a company,

Monod Bio, a spinout company from the University of Washington’s Institute for Protein Design, has raised $25 million to develop molecular biosensors designed to detect